1. Three- versus six-month adjuvant FOLFOX or CAPOX for high-risk stage II and stage III colon cancer patients: the efficacy results of Hellenic Oncology Research Group (HORG) participation to the International Duration Evaluation of Adjuvant Chemotherapy (IDEA) project. (22nd June 2019) Authors: Souglakos, J; Boukovinas, I; Kakolyris, S; Xynogalos, S; Ziras, N; Athanasiadis, A; Androulakis, N; Christopoulou, A; Vaslamatzis, M; Ardavanis, A; Emmanouilides, C; Bompolaki, I; Kourousis, C; Makrantonakis, P; Christofyllakis, C; Athanasiadis, E; Kentepozidis, N; Karampeazis, A; Katopodi, U; An... Journal: Annals of oncology Issue: Volume 30:Number 8(2019) Page Start: 1304 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗